KALA BIO, Inc. (KALA) vs Quince Therapeutics, Inc. (QNCX)
A side-by-side comparison of KALA BIO, Inc. and Quince Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
KALA
KALA BIO, Inc.
$0.37HealthcareDelayed quote: Oct 6, 2026, 12:20 PM EDT
QNCX
Quince Therapeutics, Inc.
$27.36HealthcareDelayed quote: Oct 6, 2026, 12:09 PM EDT
Total return — KALA vs QNCX
growth of $100 · dividends reinvested · last 7yKALA -100.0% (-78.6%/yr)QNCX -99.6% (-54.1%/yr)QNCX compounded faster over this window
Log scale — wide-divergence pair
KALA QNCX
KALA vs QNCX: by the numbers
- •QNCX is the larger company ($8M vs $7M market cap).
Metrics side by side
Valuation
| Metric | KALA | QNCX |
|---|---|---|
| P/B ratio | 0.79 | N/A |
Profitability
| Metric | KALA | QNCX |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -111.46% | -85.24% |
| ROIC | -232.05% | -107.08% |
Growth (annualized)
| Metric | KALA | QNCX |
|---|---|---|
| Total return CAGR (5Y) | -85.73% | -72.96% |
Frequently asked
- How have KALA and QNCX total returns compared?
- Over the past 5 years, KALA delivered -85.73% and QNCX delivered -72.96% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.